We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Risk of Recurrence of Depressive Episodes Can Be Predicted by fMRI Scans

By HospiMedica International staff writers
Posted on 02 Nov 2015
A new study shows that Functional Magnetic Resonance Imaging (fMRI) could help predict whether patients risk a recurrence of depressive episodes after recovery from a major depressive disorder.

The study was carried out by researchers from King’s College London (London, UK) and The University of Manchester (Manchester, UK) and was published in the journal JAMA Psychiatry.

In the study the researchers carried out fMRI scans on 64 patients, who were not on prescribed medication, and were in remission from major depressive disorder, to look for atypical connections in the brain. More...
The study participants’ brains were scanned while they experienced guilt or other self-blaming emotions, and were monitored regularly for symptoms over the following 14 months. By the end of the study 27 participants had a recurrence of the depression, while 37 participants remained in remission. Those participants with a recurrence of depression showed a higher level of connection between the anterior temporal lobe and the sub-genual region of the brain, in the fMRI scans. On the other hand those who remained in remission for a year and a control group of 39 people did not have the increased interconnectedness. The results of the study enabled the researchers to accurately predict (75%, 48 out of 64 cases) who would have another depressive episode.

Dr. Kathryn Adcock, head of neurosciences and mental health, MRC, said, “This exciting research has the potential to help identify those individuals who are more likely to suffer from recurrent episodes of depression and will therefore benefit most from long-term treatment and medication. This work could aid the discovery of new treatments for depression because clinical trials will be better able to focus on people with a more comparable disorder and experience.”

Related Links:

King’s College London
University of Manchester 



Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Blood Bank Refrigerator
MBR-705GR-PE
Silver Member
ECG Management System
NEMS Web
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.